2-acetamido-N-[1-(methylamino)-1,5-dioxopentan-2-yl]-5-(trifluoromethyl)thiophene-3-carboxamide
C14H16F3N3O4S — CID 167232717
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-acetamido-N-[1-(methylamino)-1,5-dioxopentan-2-yl]-5-(trifluoromethyl)thiophene-3-carboxamide
2-acetamido-N-[1-(methylamino)-1,5-dioxopentan-2-yl]-5-(trifluoromethyl)thiophene-3-carboxamide (PubChem CID 167232717) has the molecular formula C14H16F3N3O4S and a molecular weight of 379.36 g/mol. Its IUPAC name is 2-acetamido-N-[1-(methylamino)-1,5-dioxopentan-2-yl]-5-(trifluoromethyl)thiophene-3-carboxamide.
Molecular Properties
| Compound Name | 2-acetamido-N-[1-(methylamino)-1,5-dioxopentan-2-yl]-5-(trifluoromethyl)thiophene-3-carboxamide |
|---|---|
| PubChem CID | 167232717 |
| Molecular Formula | C14H16F3N3O4S |
| Molecular Weight | 379.36 g/mol |
| Exact Mass | 379.08 |
| IUPAC Name | 2-acetamido-N-[1-(methylamino)-1,5-dioxopentan-2-yl]-5-(trifluoromethyl)thiophene-3-carboxamide |
| SMILES | CNC(=O)C(CCC=O)NC(=O)c1cc(C(F)(F)F)sc1NC(C)=O |
| InChI | InChI=1S/C14H16F3N3O4S/c1-7(22)19-13-8(6-10(25-13)14(15,16)17)11(23)20-9(4-3-5-21)12(24)18-2/h5-6,9H,3-4H2,1-2H3,(H,18,24)(H,19,22)(H,20,23) |
| InChIKey | FDBGCADZTRPCMU-UHFFFAOYSA-N |
| XLogP | 1.55 |
| TPSA | 104.37 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 379.36 |
| LogP ≤ 5 | 1.55 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'aldehyde', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 167232717 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.